Glycorex Transplantation says study validates Glycosorb ABO device for platelet prep

An independent study published in Transfusion found Glycorex Transplantation's Glycosorb ABO device lowered problematic blood-group antibodies to safer levels while largely preserving platelet yield, supporting production of more flexible "universal" low-titer platelets.